Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,012 | 46,982 | 47,641 | 48,142 | 5,446 |
| Receivables | N/A | N/A | 28 | 31 | 485 |
| Other current assets | 331 | 405 | 85 | 59 | 62 |
| TOTAL | $47,343 | $47,387 | $47,754 | $48,232 | $5,993 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 359 | 202 | 0 | 0 | 485 |
| TOTAL | $359 | $202 | $N/A | $N/A | $485 |
| Total Assets | $47,702 | $47,589 | $47,754 | $48,232 | $6,478 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 331 | 331 | 331 | 302 | 324 |
| Accrued Expenses | 108 | 93 | 72 | 110 | 99 |
| Other current liabilities | 1,275 | 1,275 | N/A | N/A | N/A |
| TOTAL | $1,714 | $1,699 | $403 | $412 | $423 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,714 | $1,699 | $403 | $412 | $423 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,215 | 74,215 | 74,215 | 74,215 | 44,215 |
| Common Shares | 742 | 742 | 742 | 742 | 442 |
| Retained earnings | -70,670 | -72,043 | -71,857 | -71,388 | -70,077 |
| TOTAL | $45,988 | $45,890 | $47,351 | $47,820 | $6,055 |
| Total Liabilities And Equity | $47,702 | $47,589 | $47,754 | $48,232 | $6,478 |